William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 20,000 shares at $74.02 ($1.5M) on 2020-05-18, disclosed to the SEC on 2020-06-03.
Seasonal sale ($1.5M) by Director — this insider has traded RARE in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |
| RARE | SELL | 2018-12-07 | $298K | — | Filing → |